Edgewise Therapeutics, Inc. Insider Transactions
Edgewise Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 4,800 @ $20.04 | $96,209 | 7,020 | 02/09/2024 | 02/09/2024 | ||
|
MOORE JOHN R
General Counsel |
Sell | 3,813 @ $20.01 | $76,285 | 0 | 02/08/2024 | 02/09/2024 | |
| Sell | 4,600 @ $20.01 | $92,049 | 7,020 | 02/08/2024 | 02/09/2024 | ||
|
MOORE JOHN R
General Counsel |
Sell | 17,993 @ $20.00 | $359,864 | 0 | 02/07/2024 | 02/09/2024 | |
| Sell | 600 @ $20.00 | $12,000 | 7,020 | 02/07/2024 | 02/09/2024 | ||
| Sell | 90,000 @ $15.78 | $1.42 M | 29,024 | 01/23/2024 | 01/25/2024 | ||
|
Thompson Peter A.
Director, 10 percent owner: |
Buy | 454,545 @ $11.00 | $5.00 M | 14,436,497 | 01/23/2024 | 01/25/2024 | |
|
ORBIMED ADVISORS LLC
Director, 10 percent owner: |
Buy | 454,545 @ $11.00 | $5.00 M | 14,436,497 | 01/23/2024 | 01/25/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 8,497 @ $10.50 | $89,219 | 0 | 12/27/2023 | 12/28/2023 | |
|
Fox Jonathan C
Director |
Buy | 10,857 @ $9.30 | $100,958 | 10,857 | 12/26/2023 | 12/28/2023 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 172,585 @ $9.33 | $1.61 M | 3,606 | 12/26/2023 | 12/28/2023 | |
| Sell | 1,747 @ $8.90 | $15,557 | 7,020 | 05/02/2023 | 05/03/2023 | ||
|
MOORE JOHN R
General Counsel |
Sell | 1,897 @ $8.90 | $16,893 | 6,565 | 05/02/2023 | 05/03/2023 | |
| Sell | 1,336 @ $8.90 | $11,897 | 16,126 | 05/02/2023 | 05/03/2023 | ||
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 1,602 @ $8.90 | $14,266 | 176,191 | 05/02/2023 | 05/03/2023 | |
| Sell | 3,254 @ $8.90 | $28,977 | 9,960 | 05/02/2023 | 05/03/2023 | ||
|
KOCH KEVIN
CEO |
Sell | 3,203 @ $8.90 | $28,522 | 7,213 | 05/02/2023 | 05/03/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edgewise Therapeutics, Inc. FAQ's
The list of insiders at Edgewise Therapeutics, Inc. includes Derakhshan Behrad, Russell Alan J, MOORE JOHN R, Donovan Joanne M., Carruthers R Michael, KOCH KEVIN, Semigran Marc.
Insiders have sold a total of 464,194 Edgewise Therapeutics, Inc. shares in the last 12 months for a total of 13.00 M sold.
The following insiders have sold Edgewise Therapeutics, Inc. shares in the last 12 months: Derakhshan Behrad ($1.25 M), Russell Alan J ($4.89 M), MOORE JOHN R ($2.03 M), Donovan Joanne M. ($272,230), Carruthers R Michael ($3.61 M), KOCH KEVIN ($59,604), Semigran Marc ($881,915),